Näytä suppeat kuvailutiedot

Association Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later

Karrasch Mira; Shinnar Shlomo; Rinne Juha O; Anttinen Anu; Hermann Bruce; Sillanpää Matti; Joutsa Juho

dc.contributor.authorKarrasch Mira
dc.contributor.authorShinnar Shlomo
dc.contributor.authorRinne Juha O
dc.contributor.authorAnttinen Anu
dc.contributor.authorHermann Bruce
dc.contributor.authorSillanpää Matti
dc.contributor.authorJoutsa Juho
dc.date.accessioned2022-10-28T13:28:23Z
dc.date.available2022-10-28T13:28:23Z
dc.identifier.urihttps://www.utupub.fi/handle/10024/165419
dc.description.abstract<p>IMPORTANCE The effect of childhood epilepsy on later-life cognitive and brain health is an unclear and little-explored issue.OBJECTIVE To determine whether adults with a history of childhood-onset epilepsy exhibit increased brain amyloid accumulation, possibly predisposing to accelerated cognitive impairment or even frank cognitive disorders in later life.</p><p>DESIGN, SETTING, AND PARTICIPANTS Forty-one adults from a population-based cohort of individuals childhood-onset epilepsy in southwestern Finland, together with 46 matched population-based controls, with underwent amyloid ligand carbon 11-labeled Pittsburgh Compound B (PiB) positron emission tomography after long-term prospective follow-up. The PiB uptake was quantified as a region to cerebellar cortex ratio. Tracer uptake was evaluated visually and analyzed voxel by voxel over the entire brain to investigate the spatial distribution of amyloid deposition. The study was conducted from May 2011 to October 2013; data analysis was performed from January 2014 to October 2016.</p><p>MAIN OUTCOMES AND MEASURES Brain amyloid accumulation.RESULTS The 41 individuals with epilepsy were originally enrolled in the Turku Adult Childhood Onset Epilepsy study at the mean (SD) age of 5.1 (4.5) years (range, 0-14 years). After a mean 52.5 (4.0) years of follow-up, the participants were evaluated (26 [63%] were women; the mean [SD] age was 56.0 [4.3] years). Nine individuals with childhood-onset epilepsy (22%) and 3 control participants (7%) had a visually abnormal PiB scan showing high cortical uptake in at least 1 of the evaluated brain regions (P=.04). In semiquantitative analyses, there was a significant interaction effect indicating higher prefrontal cortex uptake in apolipoprotein E (APOE) epsilon 4 allele carriers than in noncarriers in participants (mean [SD], 1.66 [0.41] vs 1.43 [0.15]) compared with controls (1.40 [0.26) vs 1.41 [0.12]) (group x APOE interaction, F= 6.8; P=.01). In addition, there was a significant group effect showing higher tracer uptake in participants compared with controls (group effect, F= 8.0; P=.006).</p><p>CONCLUSIONS AND RELEVANCE Adults with childhood-onset epilepsy, particularly APOE e4 carriers, have an increased brain amyloid load at late middle age. Thus, epilepsy is linked with a biomarker that might be related to accelerated brain aging and can be considered a neurobiological predisposition to later-life cognitive disorders.</p>
dc.language.isoen
dc.publisherAMER MEDICAL ASSOC
dc.titleAssociation Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later
dc.identifier.urnURN:NBN:fi-fe2021042716928
dc.relation.volume74
dc.contributor.organizationfi=lastentautioppi|en=Paediatrics and Adolescent Medicine|
dc.contributor.organizationfi=PÄÄT Lasten neurologia|en=PÄÄT Paediatric Neurology|
dc.contributor.organizationfi=kliiniset neurotieteet|en=Clinical Neurosciences|
dc.contributor.organizationfi=PET perustoiminta|en=PET Basic Operations|
dc.contributor.organizationfi=kliinisen laitoksen yhteiset|en=Department of Clinical Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, vsshp|
dc.contributor.organization-code2607314
dc.contributor.organization-code2607300
dc.contributor.organization-code2609810
dc.contributor.organization-code2607313
dc.contributor.organization-code2607325
dc.converis.publication-id24558432
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/24558432
dc.format.pagerange583
dc.format.pagerange590
dc.identifier.eissn2168-6157
dc.identifier.jour-issn2168-6149
dc.okm.affiliatedauthorRinne, Juha
dc.okm.affiliatedauthorSillanpää, Matti
dc.okm.affiliatedauthorJoutsa, Juho
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.affiliatedauthorAnttinen, Anu
dc.okm.discipline3124 Neurology and psychiatryen_GB
dc.okm.discipline3124 Neurologia ja psykiatriafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeJournal article
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.countryUnited Statesen_GB
dc.publisher.country-codeUS
dc.relation.doi10.1001/jamaneurol.2016.6091
dc.relation.ispartofjournalJAMA Neurology
dc.relation.issue5
dc.year.issued2017


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot